MetaADEDB 2.0 @ LMMD
3-O-Ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(QWCYQCQLAZCPHO-UHFFFAOYSA-N)
Structure
SMILES
CCCCC(=O)N(C(C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1n[nH]nn1.NCCOCC1=C(C(=O)OCC)C(C(=C(N1)C)C(=O)OC)c1ccccc1Cl
Molecular Formula:
C44H54ClN7O8
Molecular Weight:
844.395
Log P:
7.4571
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
4
TPSA:
211.95
CAS Number(s):
N/A
Synonym(s)
1.
3-O-Ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
External Link(s)
PubChem Compound139033603
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AstheniaFAERS: 2US FAERS
2DizzinessFAERS: 2US FAERS
3Product substitution issueFAERS: 2US FAERS
4AngioedemaFAERS: 1US FAERS
5ArthralgiaFAERS: 1US FAERS
6Blood pressure inadequately controlledFAERS: 1US FAERS
7Bone painFAERS: 1US FAERS
8Chest PainFAERS: 1US FAERS
9CholecystitisFAERS: 1US FAERS
10Diabetes MellitusFAERS: 1US FAERS
11Drug ineffectiveFAERS: 1US FAERS
12HeadacheFAERS: 1US FAERS
13MyalgiaFAERS: 1US FAERS
14Oropharyngeal painFAERS: 1US FAERS
15Secretion dischargeFAERS: 1US FAERS
16SomnolenceFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.